Investing.com Deals and strategy
Earnings call transcript: DocGo misses Q2 2026 estimates as stock falls after hours
DocGo reported Q2 2026 results that missed Wall Street expectations, with an adjusted loss per share of $0.16 and revenue of $73.4 million. The company's stock fell 11.28% after hours despite a regular-session gain, due to the earnings miss, a wider full-year loss outlook, and plans for a Hicuity Health acquisition. DocGo aims for positive adjusted EBITDA run …